1. Home
  2. FLY vs PRAX Comparison

FLY vs PRAX Comparison

Compare FLY & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FLY

Firefly Aerospace Inc.

HOLD

Current Price

$27.28

Market Cap

7.9B

Sector

Industrials

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$302.19

Market Cap

7.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
PRAX
Founded
2017
2015
Country
United States
United States
Employees
1409
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.9B
7.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FLY
PRAX
Price
$27.28
$302.19
Analyst Decision
Buy
Strong Buy
Analyst Count
9
15
Target Price
$38.88
$572.13
AVG Volume (30 Days)
8.8M
531.7K
Earning Date
05-04-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$174.79
N/A
Revenue Next Year
$66.73
$7,758.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$16.00
$37.25
52 Week High
$62.17
$366.52

Technical Indicators

Market Signals
Indicator
FLY
PRAX
Relative Strength Index (RSI) 35.99 53.66
Support Level $18.95 $282.49
Resistance Level $28.74 $327.65
Average True Range (ATR) 3.91 17.76
MACD -1.37 5.20
Stochastic Oscillator 0.23 92.68

Price Performance

Historical Comparison
FLY
PRAX

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: